Cargando…
L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model
One of the most important risk factors for developing chronic kidney disease (CKD) is diabetes. To assess the safety and efficacy of potential drug candidates, reliable animal models that mimic human diseases are crucial. However, a suitable model of diabetic kidney disease (DKD) is currently not av...
Autores principales: | Corremans, Raphaëlle, D’Haese, Patrick C., Vervaet, Benjamin A., Verhulst, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657539/ https://www.ncbi.nlm.nih.gov/pubmed/34884571 http://dx.doi.org/10.3390/ijms222312767 |
Ejemplares similares
-
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
por: Corremans, Raphaëlle, et al.
Publicado: (2023) -
Metformin: A Candidate Drug for Renal Diseases
por: Corremans, Raphaëlle, et al.
Publicado: (2018) -
Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure
por: Neven, Ellen, et al.
Publicado: (2020) -
Environmental toxin-induced acute kidney injury
por: Vervaet, Benjamin A, et al.
Publicado: (2017) -
Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice
por: Le Clef, Nathalie, et al.
Publicado: (2016)